4452:TSEKao Corporation Analysis
Data as of 2026-07-23 - not real-time
¥3,224.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Kao Corporation trades around ¥3,224, comfortably above its 20‑day SMA (¥3,259) but still below the 200‑day SMA (¥3,137), indicating a neutral trend. The 14‑day RSI sits at 51.9, suggesting no immediate overbought or oversold pressure, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term downside momentum. Volume has been decreasing, and the price is approaching the identified resistance at ¥3,360, adding to the technical caution. On the valuation side, the DCF‑derived fair value of ¥2,027 is well below the current price, flagging the stock as potentially overvalued despite a forward PE of 12.5 that implies growth expectations are priced in. The company’s dividend yield of 2.41% with a 66% payout ratio appears sustainable given strong operating cash flow and a free cash flow generation of ¥108 bn. Fundamentally, revenue grew 6% YoY to ¥1.71 trn, margins remain healthy (gross 39.7%, operating 10.9%), and ROE is 11.9%, reflecting solid profitability. Analysts (13) rate the stock as a “buy” with a median target of ¥3,650, indicating an upside of roughly 14% from today’s level. However, the debt‑to‑equity ratio of 21.8 is high for a consumer‑defensive firm, and the beta of –0.13 signals low market sensitivity but also potential idiosyncratic risk. Overall, the blend of defensive sector positioning, attractive dividend, and growth prospects supports a medium‑term bullish case, while technical signals and valuation gaps temper short‑term enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and signal line
- Decreasing volume trend
- Price nearing resistance at ¥3,360
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus buy with median target ¥3,650
- Forward PE of 12.5 indicating earnings growth pricing
- Sustainable dividend yield of 2.41% with strong cash flow
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Defensive consumer sector resilience
- Solid profitability and ROE
- Elevated debt‑to‑equity ratio requiring monitoring
Key Metrics & Analysis
Financial Health
Revenue Growth6.00%
Profit Margin7.49%
P/E Ratio27.8
ROE11.93%
ROA6.30%
Debt/Equity21.83
P/B Ratio2.7
Op. Cash Flow¥202.8B
Free Cash Flow¥107.9B
Technical Analysis
TrendNeutral
RSI51.9
Support¥3,047.50
Resistance¥3,360.00
MA 20¥3,258.53
MA 50¥3,108.63
MA 200¥3,136.91
MACDBearish
VolumeDecreasing
Fear & Greed Index87.32
Valuation
Fair Value¥2,026.73
Target Price¥3,696.15
Upside/Downside14.64%
GradeOvervalued
TypeBlend
Dividend Yield2.41%
Risk Assessment
Beta-0.13
Volatility23.29%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.